243 related articles for article (PubMed ID: 20953141)
21. Identification of beta-catenin as a target of the intracellular tyrosine kinase PTK6.
Palka-Hamblin HL; Gierut JJ; Bie W; Brauer PM; Zheng Y; Asara JM; Tyner AL
J Cell Sci; 2010 Jan; 123(Pt 2):236-45. PubMed ID: 20026641
[TBL] [Abstract][Full Text] [Related]
22. Targeting protein tyrosine kinase 6 in cancer.
Gilic MB; Tyner AL
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188432. PubMed ID: 32956764
[TBL] [Abstract][Full Text] [Related]
23. Proapoptotic function of the nuclear Crk II adaptor protein.
Kar B; Reichman CT; Singh S; O'Connor JP; Birge RB
Biochemistry; 2007 Sep; 46(38):10828-40. PubMed ID: 17764157
[TBL] [Abstract][Full Text] [Related]
24. Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK.
Brauer PM; Tyner AL
Biochim Biophys Acta; 2010 Aug; 1806(1):66-73. PubMed ID: 20193745
[TBL] [Abstract][Full Text] [Related]
25. An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6.
Kim HIe; Lee ST
J Biol Chem; 2005 Aug; 280(32):28973-80. PubMed ID: 15961400
[TBL] [Abstract][Full Text] [Related]
26. Interference of PTK6/GAB1 signaling inhibits cell proliferation, invasion, and migration of cervical cancer cells.
Li J; Yang N; Tian X; Ouyang L; Jiang M; Zhang S
Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35894144
[TBL] [Abstract][Full Text] [Related]
27. Vemurafenib Inhibits Active PTK6 in
Wozniak DJ; Hitchinson B; Gilic MB; Bie W; Gaponenko V; Tyner AL
Mol Cancer Ther; 2019 May; 18(5):937-946. PubMed ID: 30926642
[TBL] [Abstract][Full Text] [Related]
28. STAT2 nuclear trafficking.
Banninger G; Reich NC
J Biol Chem; 2004 Sep; 279(38):39199-206. PubMed ID: 15175343
[TBL] [Abstract][Full Text] [Related]
29. Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane.
Gierut J; Zheng Y; Bie W; Carroll RE; Ball-Kell S; Haegebarth A; Tyner AL
Gastroenterology; 2011 Oct; 141(4):1371-80, 1380.e1-2. PubMed ID: 21741923
[TBL] [Abstract][Full Text] [Related]
30. Targeting protein tyrosine kinase 6 enhances apoptosis of colon cancer cells following DNA damage.
Gierut JJ; Mathur PS; Bie W; Han J; Tyner AL
Mol Cancer Ther; 2012 Nov; 11(11):2311-20. PubMed ID: 22989419
[TBL] [Abstract][Full Text] [Related]
31. Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II.
Liu J; Rothermund CA; Ayala-Sanmartin J; Vishwanatha JK
BMC Biochem; 2003 Sep; 4():10. PubMed ID: 12962548
[TBL] [Abstract][Full Text] [Related]
32. Sam68 enhances the cytoplasmic utilization of intron-containing RNA and is functionally regulated by the nuclear kinase Sik/BRK.
Coyle JH; Guzik BW; Bor YC; Jin L; Eisner-Smerage L; Taylor SJ; Rekosh D; Hammarskjöld ML
Mol Cell Biol; 2003 Jan; 23(1):92-103. PubMed ID: 12482964
[TBL] [Abstract][Full Text] [Related]
33. RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival.
Yu G; Lee YC; Cheng CJ; Wu CF; Song JH; Gallick GE; Yu-Lee LY; Kuang J; Lin SH
Mol Cancer Res; 2015 Feb; 13(2):348-57. PubMed ID: 25189355
[TBL] [Abstract][Full Text] [Related]
34. Ste11p, a high-mobility-group box DNA-binding protein, undergoes pheromone- and nutrient-regulated nuclear-cytoplasmic shuttling.
Qin J; Kang W; Leung B; McLeod M
Mol Cell Biol; 2003 May; 23(9):3253-64. PubMed ID: 12697825
[TBL] [Abstract][Full Text] [Related]
35. A nuclear export signal and phosphorylation regulate Dok1 subcellular localization and functions.
Niu Y; Roy F; Saltel F; Andrieu-Soler C; Dong W; Chantegrel AL; Accardi R; Thépot A; Foiselle N; Tommasino M; Jurdic P; Sylla BS
Mol Cell Biol; 2006 Jun; 26(11):4288-301. PubMed ID: 16705178
[TBL] [Abstract][Full Text] [Related]
36. The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer.
Wang XJ; Xiong Y; Ma ZB; Xia JC; Li YF
Chin J Cancer; 2016 Jun; 35(1):54. PubMed ID: 27311570
[TBL] [Abstract][Full Text] [Related]
37. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
38. Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer.
Ludyga N; Anastasov N; Gonzalez-Vasconcellos I; Ram M; Höfler H; Aubele M
Mol Biosyst; 2011 May; 7(5):1603-12. PubMed ID: 21380407
[TBL] [Abstract][Full Text] [Related]
39. Protein tyrosine kinase 6 regulates activation of SRC kinase.
Alwanian WM; Vlajic K; Bie W; Kajdacsy-Balla A; Tyner AL
J Biol Chem; 2022 Nov; 298(11):102584. PubMed ID: 36228719
[TBL] [Abstract][Full Text] [Related]
40. The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2.
Haegebarth A; Heap D; Bie W; Derry JJ; Richard S; Tyner AL
J Biol Chem; 2004 Dec; 279(52):54398-404. PubMed ID: 15471878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
